OR WAIT null SECS
Article
Drop tolerance, adherence remain challenges for physicians and patients with glaucoma.
Study: Neurolenses significantly impact reading speed
FDA approves biosimilar product ranibizumab-eqrn for retinal diseases
Aerie doses first patient in COMET-3 study for DED treatment
EyeCare4Kids names new executive director